Sales and Marketing

Showing 15 posts of 11524 posts found.

Lundbeck launches sleep awareness campaign

March 20, 2009 Sales and Marketing Lundbeck, sleep

Lundbeck has launched a campaign aiming to raise awareness of insomnia and sleep problems. 'Sleep well, Live well ' is …

Shire withdraws ADHD patch filing

March 19, 2009 Research and Development, Sales and Marketing Shire

Shire has withdrawn the European marketing application for its Attention Deficit Hyperactivity Disorder (ADHD) patch product Daytrana. The product's active …

Sanofi boosted by Multaq vote of approval

March 19, 2009 Research and Development, Sales and Marketing FDA, Multaq, Sanofi, US

An FDA committee has recommended Sanofi-Aventis' new atrial fibrillation treatment Multaq, the company's most important late-stage drug. The FDA cardiovascular …

FDA to review Xarelto safety concerns

March 19, 2009 Research and Development, Sales and Marketing Xarelto

Anti-blood clotting drug Xarelto could fail to win approval in the US due to safety concerns. The FDA has convened …

ProStrakan ‘on target’ to break-even this year

March 19, 2009 Sales and Marketing ProStrakan

ProStrakan says it will move into the black later this year, after sales rose by a third and its operating …

Getting the most out of your product portfolio

March 17, 2009 Research and Development, Sales and Marketing portfolio, product

Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …

Unlocking the value of social media for business customers

March 17, 2009 Medical Communications, Sales and Marketing marketing, social networking

Conversations around social media dominate the marketing landscape. Twitter-mania has reached fever pitch, proclaiming it the latest 'must have' social …

Merck’s mega-merger will mark a return to sales growth

March 16, 2009 Sales and Marketing MA, Merck

As a standalone company, Merck & Co. faces a tough future of declining sales. Analysts Datamonitor forecast that the merger …

Blow for Genzyme as FDA finds fault with Allston facility

March 13, 2009 Research and Development, Sales and Marketing FDA, Genzyme

The chances of approval for Genzyme's new Pompe disease drug Lumizyme have diminished dramatically after the US Food and Drug …

Working Life: Andrew Clark

March 13, 2009 Research and Development, Sales and Marketing UCB, library

How did you find your way into your current role? On return from a working holiday to New Zealand I …

Roche buys out Genentech with increased bid

March 12, 2009 Sales and Marketing MA, Roche

Roche has finally struck a deal to acquire Genentech after raising its cash offer, putting an end to a prolonged …
The Gateway to Local Adoption Series

Latest content